MODL-17. The Childhood Brain Cancer Cell Line Atlas: A Resource for Biomarker Identification and Therapeutic Development
Paul Daniel(Brigham and Women's Hospital), Ron Firestein(Unknown), Javad Nazarian(University Children's Hospital Zurich), Maria Vinci(Cancer Research UK), Matt Dun(University of Newcastle Australia), Amos Hong Pheng Loh(KK Women's and Children's Hospital), Motahhareh Tourchi(Hudson Institute of Medical Research), Michelle Monje(Howard Hughes Medical Institute), Louise Ludlow(Murdoch Children's Research Institute), Duncan E. Crombie(Monash University), Claire Sun(Hudson Institute of Medical Research), Chris Jones(North Carolina State University), Claire Shi(Hudson Institute of Medical Research), Dilru Habarakada(Monash University), David S. Ziegler(Cancer Institute of New South Wales), Sharon Y. Y. Low(National Neuroscience Institute), Eric H. Raabe(Johns Hopkins University), Nicole J. Chew(Australian Regenerative Medicine Institute), Jeffrey Rubens(Johns Hopkins University), Melissa Loi(Monash University), Naama Neeman(Hudson Institute of Medical Research), Wai Chin Chong(Hudson Institute of Medical Research), Nataliya Zhukova, Jason E. Cain(Monash Medical Centre), Mateusz Koptyra(Children's Hospital of Philadelphia), Daniel J. Gough(Hudson Institute of Medical Research), Gabrielle Bradshaw(Hudson Institute of Medical Research), Adam Resnick(Children's Hospital of Philadelphia), Jamie I. Fletcher(Cancer Institute of New South Wales), Paul G. Ekert(Royal Children's Hospital), Sarah Parackal(Monash University), Shazia Adjumain(Hudson Institute of Medical Research), Dasun Fernando(Monash University), Hoang Nguyen(Hudson Institute of Medical Research), Caroline Drinkwater(Monash University), Bryan Williams(Hudson Institute of Medical Research), Dhanya Sooraj(Royal Perth Hospital)
Cited by 1
Related Papers
Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation
|BMC Biology|2012|1k
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
|Journal of Clinical Oncology|2016|867
Analysis and Visualization of Longitudinal Genomic and Clinical Data from the AACR Project GENIE Biopharma Collaborative in cBioPortal
|Cancer Research|2023|847
Comprehensive Analysis of Hypermutation in Human Cancer
|Cell|2017|795